Marc Short, the chief of staff to Vice President Pence, owns between $506,043 and $1.64 million worth of individual stocks in companies doing work related to the Trump administration's pandemic response — holdings that could run afoul of conflict of interest laws.
In the TV ad that launched earlier this month, the character hides in the bushes as two women drink coffee and chat as they eat lunch on a nearby bench. The flame with legs never talks. It just giggles as it chases off one of the women, who didn’t take her heartburn medicine.
It was immediately challenged at several high courts across the country, with Delhi receiving the most number of petitions. Pfizer, Glenmark, Procter & Gamble, Abbott, Sanofi, Cipla, Lupin and Dr Reddy's figure among the hundreds of petitioners that opposed the ban.
Church & Dwight Co., the maker of Trojan condoms and Arm & Hammer baking soda, rose the most in more than eight years on reports that it might be a takeover target.
Pharma companies today told Delhi High Court that the government's decision to ban 344 fixed drug combinations (FDCs) was taken without considering any clinical data.
The Delhi High Court is likely to resume tomorrow the hearing on pleas by over 30 pharma majors, including Pfizer, Glenmark, Procter and Gamble (P&G) and Cipla, challenging the government's decision to ban sale of some of their fixed dose combination medicines.
Health foods and consumer goods maker GSK Consumer has stopped sale of Crocin Cold & Flu, after the Government announced a ban on sale of fixed dose combination drugs (FDCs).
U.S. consumer health group Procter & Gamble's Indian business plans to challenge a government ban on its cough-and-cold medicine Vicks Action 500 Extra, citing potential health risks.
U.S. consumer health giant Procter & Gamble's India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk.
Johnson & Johnson (NYSE:JNJ), the largest drug maker globally, could be expected to consider splitting itself up. Activists are said to be urging the drug maker to consider the option, as the estimated combined value of Johnson & Johnson's three businesses is greater than the company’s current individual value.